Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma (Q34538364)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma
scientific article

    Statements

    Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma (English)
    Igor A Astsaturov
    Neal J Meropol
    Barbara A Burtness
    Jonathan D Cheng
    Sue McLaughlin
    André Rogatko
    James C Watson
    Louis M Weiner
    Steven J Cohen
    1 February 2011

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit